In January 2025, we reported that some adverse events associated with gabapentin (Neurontin) may have been overestimated.

An analysis of major depressive disorder, covering diagnostic criteria, prevalence statistics across demographics, and ...

Sight Sciences stock surged on Medicare coverage for TearCare—opening a big dry eye market. Learn more about the company.

A review in Current Allergy and Asthma Reports highlights how acute exacerbations of chronic rhinosinusitis (AECRS) remain poorly defined, inconsistently diagnosed, and often overtreated with ...

A high risk of obstructive sleep apnea (OSA) was associated with higher odds of a composite of depression and mental health ...

Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access ...

Health system CEOs across the U.S. launched and expanded efforts in 2025 to improve access to care, enhance patient and provider experience and reduce costs. Becker’s connected with five health system ...

Strength The Strength card that appears in 2026 will very softly train you to be calm and powerful. You will stop wanting to ...

New research commissioned by Public Health Wales has revealed key insights into how people with Type 2 diabetes in Wales can ...

Last week, a 44-year old father of two died after eight hours in the waiting room of Edmonton’s Grey Nuns hospital. It’s ...

Designed to empower users to understand the causes of their headaches, the app now includes a suite of tools to log symptoms, analyze, track treatment efficacy We created this app to address a very ...

In this Waste360 Q&A, Kristin Aldred discusses existing rules around home healthcare waste disposal and gaps in regulation ...